Global Neurovascular Devices/Interventional Neurology Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Neurovascular Devices/Interventional Neurology market report explains the definition, types, applications, major countries, and major players of the Neurovascular Devices/Interventional Neurology market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Stryker Corporation

    • W L Gore & Associates

    • Terumo

    • Johnson & Johnson

    • Medtronic

    • Abbott Vascular

    • Microport Scientific Corporation

    • Penumbra

    By Type:

    • Aneurysm Coiling & Embolization Devices

    • Cerebral Balloon Angioplasty & Stenting Systems

    • Support Devices

    • Neurothrombectomy Devices

    By End-User:

    • Hospitals & surgical centers

    • Ambulatory care centers

    • Research laboratories & academic institutes

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Neurovascular Devices/Interventional Neurology Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Neurovascular Devices/Interventional Neurology Outlook to 2028- Original Forecasts

    • 2.2 Neurovascular Devices/Interventional Neurology Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Neurovascular Devices/Interventional Neurology Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Neurovascular Devices/Interventional Neurology Market- Recent Developments

    • 6.1 Neurovascular Devices/Interventional Neurology Market News and Developments

    • 6.2 Neurovascular Devices/Interventional Neurology Market Deals Landscape

    7 Neurovascular Devices/Interventional Neurology Raw Materials and Cost Structure Analysis

    • 7.1 Neurovascular Devices/Interventional Neurology Key Raw Materials

    • 7.2 Neurovascular Devices/Interventional Neurology Price Trend of Key Raw Materials

    • 7.3 Neurovascular Devices/Interventional Neurology Key Suppliers of Raw Materials

    • 7.4 Neurovascular Devices/Interventional Neurology Market Concentration Rate of Raw Materials

    • 7.5 Neurovascular Devices/Interventional Neurology Cost Structure Analysis

      • 7.5.1 Neurovascular Devices/Interventional Neurology Raw Materials Analysis

      • 7.5.2 Neurovascular Devices/Interventional Neurology Labor Cost Analysis

      • 7.5.3 Neurovascular Devices/Interventional Neurology Manufacturing Expenses Analysis

    8 Global Neurovascular Devices/Interventional Neurology Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Neurovascular Devices/Interventional Neurology Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Neurovascular Devices/Interventional Neurology Export by Region (Top 10 Countries) (2017-2028)

    9 Global Neurovascular Devices/Interventional Neurology Market Outlook by Types and Applications to 2022

    • 9.1 Global Neurovascular Devices/Interventional Neurology Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Aneurysm Coiling & Embolization Devices Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cerebral Balloon Angioplasty & Stenting Systems Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Support Devices Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Neurothrombectomy Devices Consumption and Growth Rate (2017-2022)

    • 9.2 Global Neurovascular Devices/Interventional Neurology Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals & surgical centers Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ambulatory care centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research laboratories & academic institutes Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Neurovascular Devices/Interventional Neurology Market Analysis and Outlook till 2022

    • 10.1 Global Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.2.2 Canada Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.2.3 Mexico Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.2 UK Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.3 Spain Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.4 Belgium Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.5 France Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.6 Italy Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.7 Denmark Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.8 Finland Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.9 Norway Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.10 Sweden Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.11 Poland Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.12 Russia Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.3.13 Turkey Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.2 Japan Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.3 India Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.4 South Korea Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.5 Pakistan Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.6 Bangladesh Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.7 Indonesia Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.8 Thailand Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.9 Singapore Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.10 Malaysia Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.11 Philippines Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.4.12 Vietnam Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.5.2 Colombia Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.5.3 Chile Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.5.4 Argentina Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.5.5 Venezuela Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.5.6 Peru Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.5.7 Puerto Rico Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.5.8 Ecuador Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.6.2 Kuwait Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.6.3 Oman Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.6.4 Qatar Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.7.2 South Africa Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.7.3 Egypt Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.7.4 Algeria Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

      • 10.8.2 New Zealand Neurovascular Devices/Interventional Neurology Consumption (2017-2022)

    11 Global Neurovascular Devices/Interventional Neurology Competitive Analysis

    • 11.1 Stryker Corporation

      • 11.1.1 Stryker Corporation Company Details

      • 11.1.2 Stryker Corporation Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Stryker Corporation Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.1.4 Stryker Corporation Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 W L Gore & Associates

      • 11.2.1 W L Gore & Associates Company Details

      • 11.2.2 W L Gore & Associates Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 W L Gore & Associates Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.2.4 W L Gore & Associates Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Terumo

      • 11.3.1 Terumo Company Details

      • 11.3.2 Terumo Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Terumo Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.3.4 Terumo Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Johnson & Johnson

      • 11.4.1 Johnson & Johnson Company Details

      • 11.4.2 Johnson & Johnson Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Johnson & Johnson Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.4.4 Johnson & Johnson Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Medtronic

      • 11.5.1 Medtronic Company Details

      • 11.5.2 Medtronic Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Medtronic Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.5.4 Medtronic Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Abbott Vascular

      • 11.6.1 Abbott Vascular Company Details

      • 11.6.2 Abbott Vascular Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Abbott Vascular Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.6.4 Abbott Vascular Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Microport Scientific Corporation

      • 11.7.1 Microport Scientific Corporation Company Details

      • 11.7.2 Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.7.4 Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Penumbra

      • 11.8.1 Penumbra Company Details

      • 11.8.2 Penumbra Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Penumbra Neurovascular Devices/Interventional Neurology Main Business and Markets Served

      • 11.8.4 Penumbra Neurovascular Devices/Interventional Neurology Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Neurovascular Devices/Interventional Neurology Market Outlook by Types and Applications to 2028

    • 12.1 Global Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Aneurysm Coiling & Embolization Devices Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Cerebral Balloon Angioplasty & Stenting Systems Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Support Devices Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Neurothrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals & surgical centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Ambulatory care centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Research laboratories & academic institutes Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Neurovascular Devices/Interventional Neurology Market Analysis and Outlook to 2028

    • 13.1 Global Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.2.2 Canada Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.2 UK Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.3 Spain Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.5 France Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.6 Italy Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.8 Finland Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.9 Norway Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.11 Poland Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.12 Russia Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.2 Japan Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.3 India Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.5.3 Chile Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.5.6 Peru Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.6.3 Oman Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Neurovascular Devices/Interventional Neurology Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Neurovascular Devices/Interventional Neurology

    • Figure of Neurovascular Devices/Interventional Neurology Picture

    • Table Global Neurovascular Devices/Interventional Neurology Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Neurovascular Devices/Interventional Neurology Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Aneurysm Coiling & Embolization Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Cerebral Balloon Angioplasty & Stenting Systems Consumption and Growth Rate (2017-2022)

    • Figure Global Support Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Neurothrombectomy Devices Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals & surgical centers Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory care centers Consumption and Growth Rate (2017-2022)

    • Figure Global Research laboratories & academic institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Table North America Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Figure United States Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Canada Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Mexico Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Table Europe Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Figure Germany Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure UK Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Spain Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Belgium Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure France Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Italy Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Denmark Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Finland Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Norway Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Sweden Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Poland Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Russia Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Turkey Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Table APAC Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Figure China Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Japan Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure India Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure South Korea Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Thailand Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Singapore Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Philippines Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Table South America Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Figure Brazil Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Colombia Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Chile Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Argentina Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Peru Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Table GCC Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Figure Bahrain Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Oman Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Qatar Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Table Africa Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Figure Nigeria Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure South Africa Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Egypt Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure Algeria Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Table Oceania Neurovascular Devices/Interventional Neurology Consumption by Country (2017-2022)

    • Figure Australia Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Neurovascular Devices/Interventional Neurology Consumption and Growth Rate (2017-2022)

    • Table Stryker Corporation Company Details

    • Table Stryker Corporation Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stryker Corporation Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table Stryker Corporation Neurovascular Devices/Interventional Neurology Product Portfolio

    • Table W L Gore & Associates Company Details

    • Table W L Gore & Associates Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table W L Gore & Associates Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table W L Gore & Associates Neurovascular Devices/Interventional Neurology Product Portfolio

    • Table Terumo Company Details

    • Table Terumo Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table Terumo Neurovascular Devices/Interventional Neurology Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table Johnson & Johnson Neurovascular Devices/Interventional Neurology Product Portfolio

    • Table Medtronic Company Details

    • Table Medtronic Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table Medtronic Neurovascular Devices/Interventional Neurology Product Portfolio

    • Table Abbott Vascular Company Details

    • Table Abbott Vascular Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Vascular Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table Abbott Vascular Neurovascular Devices/Interventional Neurology Product Portfolio

    • Table Microport Scientific Corporation Company Details

    • Table Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table Microport Scientific Corporation Neurovascular Devices/Interventional Neurology Product Portfolio

    • Table Penumbra Company Details

    • Table Penumbra Neurovascular Devices/Interventional Neurology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Penumbra Neurovascular Devices/Interventional Neurology Main Business and Markets Served

    • Table Penumbra Neurovascular Devices/Interventional Neurology Product Portfolio

    • Figure Global Aneurysm Coiling & Embolization Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cerebral Balloon Angioplasty & Stenting Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Support Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurothrombectomy Devices Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals & surgical centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory care centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research laboratories & academic institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Table North America Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Figure United States Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Figure Germany Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Figure China Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Figure Brazil Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Neurovascular Devices/Interventional Neurology Consumption Forecast by Country (2022-2028)

    • Figure Australia Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Neurovascular Devices/Interventional Neurology Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.